• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔癌细胞系 HRAS 和 KRAS 基因突变分析。

Mutational analysis of HRAS and KRAS genes in oral carcinoma cell lines.

机构信息

Department of Biochemistry, The Nippon Dental University, School of Life Dentistry at Tokyo, Tokyo, Japan.

出版信息

Odontology. 2012 Jul;100(2):149-55. doi: 10.1007/s10266-011-0032-3. Epub 2011 May 24.

DOI:10.1007/s10266-011-0032-3
PMID:21607592
Abstract

RAS overexpression and its active mutations are involved in malignant tumorigenesis. However, the mutation rates in oral carcinoma cells differ between populations. In the present study, genomic DNA of oral carcinoma cells (HOC313, TSU, HSC2, HSC3, KOSC2, KOSC3, SCCKN, OSC19, Ca9.22, and Ho1u1 cells) or normal gingival fibroblasts (GF12 cells) derived from a Japanese population were amplified by polymerase chain reaction using primer sets, spanning HRAS and KRAS exons. Nucleotide substitutions were analyzed by single strand conformation polymorphism. In contrast to no substitutions in KRAS, nine different substitutions were detected in HRAS. Of the nine, six substitutions were located at intron 1 (HSC2 and HSC3 cells) or intron 2 (HSC3, SCCKN and Ca9.22 cells), and one each of exon 1 (all cells), exon 2 (HOC313, TSU, HSC2 and HSC3 cells) and the 5' upstream region (all cells). Substitutions at exons 1 and 2 did not affect the amino acid sequence; the exon 1 substitution was positioned at the 5' untranslated region, which may be a single nucleotide polymorphism (SNP) sequence because all the cells were isolated from a Japanese population, and the mutations at exon 2 was a silent mutation. A substitution at the 5' upstream region was an SNP. These data demonstrate that SNPs and point mutations observed in HRAS do not change the amino acid sequence, and suggest that the mutations affecting the amino acid sequence may be a rare event in oral carcinomas of the Japanese population.

摘要

RAS 过度表达及其活性突变与恶性肿瘤的发生有关。然而,口腔癌细胞中的突变率因人群而异。在本研究中,使用引物组通过聚合酶链反应扩增了源自日本人群的口腔癌细胞(HOC313、TSU、HSC2、HSC3、KOSC2、KOSC3、SCCKN、OSC19、Ca9.22 和 Ho1u1 细胞)或正常牙龈成纤维细胞(GF12 细胞)的基因组 DNA。通过单链构象多态性分析核苷酸取代。与 KRAS 无取代相反,在 HRAS 中检测到九个不同的取代。在这九个中,有六个取代位于内含子 1(HSC2 和 HSC3 细胞)或内含子 2(HSC3、SCCKN 和 Ca9.22 细胞),一个位于外显子 1(所有细胞),一个位于外显子 2(HOC313、TSU、HSC2 和 HSC3 细胞)和 5'上游区(所有细胞)。外显子 1 和 2 的取代不影响氨基酸序列;外显子 1 的取代位于 5'非翻译区,这可能是单核苷酸多态性(SNP)序列,因为所有细胞均来自日本人群,并且外显子 2 的突变是沉默突变。5'上游区的取代是 SNP。这些数据表明,在 HRAS 中观察到的 SNP 和点突变不会改变氨基酸序列,并表明影响氨基酸序列的突变在日本人的口腔癌中可能是罕见事件。

相似文献

1
Mutational analysis of HRAS and KRAS genes in oral carcinoma cell lines.口腔癌细胞系 HRAS 和 KRAS 基因突变分析。
Odontology. 2012 Jul;100(2):149-55. doi: 10.1007/s10266-011-0032-3. Epub 2011 May 24.
2
Single nucleotide polymorphisms of mucosa-associated lymphoid tissue 1 in oral carcinoma cells and gingival fibroblasts.口腔癌细胞和牙龈成纤维细胞中黏膜相关淋巴组织1的单核苷酸多态性
Odontology. 2013 Jul;101(2):150-5. doi: 10.1007/s10266-012-0079-9. Epub 2012 Jul 3.
3
PIK3CA, HRAS and KRAS gene mutations in human penile cancer.人类阴茎癌中的PIK3CA、HRAS和KRAS基因突变
J Urol. 2008 May;179(5):2030-4. doi: 10.1016/j.juro.2007.12.040. Epub 2008 Mar 19.
4
Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.用苯并[a]芘引发的小鼠皮肤肿瘤中c-Ha-ras原癌基因的剂量依赖性突变谱。
Carcinogenesis. 1999 Sep;20(9):1689-96. doi: 10.1093/carcin/20.9.1689.
5
Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.口腔鳞状细胞癌中BRAF、KRAS和PIK3CA基因的突变分析。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Nov;110(5):632-7. doi: 10.1016/j.tripleo.2010.05.002. Epub 2010 Sep 1.
6
Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon.体细胞 RAS 突变发生于很大一部分散发性 RET 阴性甲状腺髓样癌中,并延伸至一个以前未识别的外显子。
J Clin Endocrinol Metab. 2012 Oct;97(10):E2031-5. doi: 10.1210/jc.2012-2092. Epub 2012 Aug 3.
7
Effects of KRAS mutation and polymorphism on the risk and prognosis of oral squamous cell carcinoma.KRAS 突变和多态性对口腔鳞状细胞癌风险和预后的影响。
Head Neck. 2012 May;34(5):663-6. doi: 10.1002/hed.21792. Epub 2011 Jun 17.
8
Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.对甲状腺髓样癌中的 RET、HRAS、KRAS、NRAS、BRAF、AKT1 和 CTNNB1 进行突变筛查。
Anticancer Res. 2011 Dec;31(12):4179-83.
9
Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma.人β-防御素1、2和3在口腔鳞状细胞癌中的表达缺失。
Oral Microbiol Immunol. 2009 Oct;24(5):353-60. doi: 10.1111/j.1399-302X.2009.00512.x.
10
Lack of mutational events of RAS genes in sporadic thyroid cancer but high risk associated with HRAS T81C single nucleotide polymorphism (case-control study).散发性甲状腺癌中RAS基因无突变事件,但HRAS T81C单核苷酸多态性与之相关的高风险(病例对照研究)。
Tumour Biol. 2013 Feb;34(1):521-9. doi: 10.1007/s13277-012-0577-y. Epub 2012 Nov 13.

引用本文的文献

1
Cell culture models of oral mucosal barriers: A review with a focus on applications, culture conditions and barrier properties.口腔黏膜屏障的细胞培养模型:聚焦于应用、培养条件及屏障特性的综述
Tissue Barriers. 2018;6(3):1479568. doi: 10.1080/21688370.2018.1479568. Epub 2018 Sep 25.
2
Single nucleotide polymorphisms of mucosa-associated lymphoid tissue 1 in oral carcinoma cells and gingival fibroblasts.口腔癌细胞和牙龈成纤维细胞中黏膜相关淋巴组织1的单核苷酸多态性
Odontology. 2013 Jul;101(2):150-5. doi: 10.1007/s10266-012-0079-9. Epub 2012 Jul 3.

本文引用的文献

1
Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma.在口腔鳞状细胞癌中,RASSF1A、RASSF2A和HIN-1的甲基化与放疗后而非手术后的不良预后相关。
Clin Cancer Res. 2009 Jun 15;15(12):4174-80. doi: 10.1158/1078-0432.CCR-08-2929. Epub 2009 Jun 9.
2
Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model.雷帕霉素可预防口腔特异性K-ras和p53双打击致癌模型中肿瘤发生的早期发作。
Cancer Res. 2009 May 15;69(10):4159-66. doi: 10.1158/0008-5472.CAN-08-4645. Epub 2009 May 12.
3
Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy.
口腔鳞状细胞癌的分子发病机制:对治疗的启示
J Dent Res. 2008 Jan;87(1):14-32. doi: 10.1177/154405910808700104.
4
TP53 mutations and survival in squamous-cell carcinoma of the head and neck.头颈部鳞状细胞癌中的TP53突变与生存情况
N Engl J Med. 2007 Dec 20;357(25):2552-61. doi: 10.1056/NEJMoa073770.
5
Epigenetic inactivation of E-cadherin by promoter hypermethylation in oral carcinoma cells.口腔癌细胞中启动子高甲基化导致E-钙黏蛋白的表观遗传失活。
Odontology. 2007 Jul;95(1):24-9. doi: 10.1007/s10266-007-0068-6. Epub 2007 Jul 25.
6
Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma.转化生长因子-β II型受体的缺失促进转移性头颈部鳞状细胞癌。
Genes Dev. 2006 May 15;20(10):1331-42. doi: 10.1101/gad.1413306.
7
An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: its potential use for preclinical chemoprevention studies.通过4-硝基喹啉1-氧化物在人c-Ha-ras原癌基因转基因大鼠中快速诱导舌肿瘤的动物模型:其在临床前化学预防研究中的潜在用途。
Carcinogenesis. 2006 Mar;27(3):619-30. doi: 10.1093/carcin/bgi241. Epub 2005 Oct 11.
8
Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity.间充质特异性基因HMGA2在口腔鳞状细胞癌中的表达。
Cancer Res. 2004 Mar 15;64(6):2024-9. doi: 10.1158/0008-5472.can-03-1855.
9
Mutations of the BRAF gene in squamous cell carcinoma of the head and neck.头颈部鳞状细胞癌中BRAF基因的突变
Oncogene. 2003 Jul 24;22(30):4757-9. doi: 10.1038/sj.onc.1206705.
10
RAS oncogenes: the first 30 years.RAS致癌基因:最初的30年。
Nat Rev Cancer. 2003 Jun;3(6):459-65. doi: 10.1038/nrc1097.